After President Biden announced he won’t accept the Democratic nomination, Alabama Republicans quickly pivoted to attacking Vice President Kamala Harris.
Merck’s drug, molnupiravir, was found to reduce hospitalizations and deaths by 30 percent, while Pfizer's antiviral pill had a nearly 90 percent reduction.